article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. percent increase since 2021, predominantly due to Botox sales for therapeutic uses. Botox brought in a total of $2.72 billion, a decrease of 9.01

Sales 98